Literature DB >> 21743837

Effect of CBT on Depressive Symptoms in Methadone Maintenance Patients Undergoing Treatment for Hepatitis C.

Susan E Ramsey1, Patricia A Engler, Michael D Stein, Richard A Brown, Patricia Cioe, Christopher W Kahler, Kittichai Promrat, Jennifer Rose, Jennifer Anthony, David A Solomon.   

Abstract

To examine the efficacy of a cognitive-behavioral intervention (CBT) to prevent depression among methadone maintenance patients undergoing antiviral treatment for hepatitis C (HCV), 29 patients beginning HCV treatment were randomized to CBT or standard care (SC). Study participants did not meet criteria for major depressive disorder at the time of study recruitment. CBT did not result in less depression-related antiviral treatment failure, better adherence to antiviral treatment, or better HCV RNA outcomes. There were no significant treatment group differences on depressive symptoms over time. The CBT group did display a greater and more consistent decline in both BDI-II and HAM-D scores over time (d=.85 on the BDI-II; d=.72 on the HAM-D).

Entities:  

Year:  2011        PMID: 21743837      PMCID: PMC3130194          DOI: 10.4172/2155-6105.1000109

Source DB:  PubMed          Journal:  J Addict Res Ther


  59 in total

Review 1.  Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review.

Authors:  E Dieperink; M Willenbring; S B Ho
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  Group cognitive and contextual therapies in treatment of depression.

Authors:  R D Zettle; J C Rains
Journal:  J Clin Psychol       Date:  1989-05

3.  Manic episodes in two patients treated with interferon alpha.

Authors:  D Strite; A D Valentine; C A Meyers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1997       Impact factor: 2.198

4.  Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study.

Authors:  Naoshi Horikawa; Tomoko Yamazaki; Namiki Izumi; Masakatsu Uchihara
Journal:  Gen Hosp Psychiatry       Date:  2003 Jan-Feb       Impact factor: 3.238

5.  Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

Authors:  Lucile Capuron; Jane F Gumnick; Dominique L Musselman; David H Lawson; Andrea Reemsnyder; Charles B Nemeroff; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

6.  Psychiatric complications of long-term interferon alfa therapy.

Authors:  P F Renault; J H Hoofnagle; Y Park; K D Mullen; M Peters; D B Jones; V Rustgi; E A Jones
Journal:  Arch Intern Med       Date:  1987-09

7.  The Modified Hamilton Rating Scale for Depression: reliability and validity.

Authors:  I W Miller; S Bishop; W H Norman; H Maddever
Journal:  Psychiatry Res       Date:  1985-02       Impact factor: 3.222

8.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

9.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  2 in total

1.  The interaction of active substance use, depression, and antiretroviral adherence in methadone maintenance.

Authors:  Howard Newville; Karina M Berg; Jeffrey S Gonzalez
Journal:  Int J Behav Med       Date:  2015-04

2.  Development and Pilot-Testing of a Cognitive Behavioral Coping Skills Group Intervention for Patients with Chronic Hepatitis C.

Authors:  Donna M Evon; Carol E Golin; Rachel Ruffin; Michael W Fried
Journal:  Contemp Clin Trials Commun       Date:  2017-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.